Synthesis of purine derivatives as scaffolds for a diversity of biological activities

Current Organic Chemistry

Volumn 14, Issue 20, 2010, Pages 2463-2482

  Conejo Garcia A ^a   Cruz Lopez O ^a   Gomez Perez V ^a   Morales, F ^a   Garcia Rubino M E ^a   Kimatrai, M ^a   Nunez M C ^a   Campos, J M ^a  

^a Facultad de Farmacia   (Spain)

Author keywords

Alkyl purine derivatives; Aryl purine derivatives; Cross coupling; Ferrocene modified purines; Fluorinated compounds; Microwave; Nucleosides; Solid phase synthesis

Indexed keywords

BIOCHEMISTRY; CATALYSTS; IRON COMPOUNDS; METAL HALIDES; NUCLEIC ACIDS; ORGANOMETALLICS; SYNTHESIS (CHEMICAL);

ALKYL-PURINE DERIVATIVE; ARYL-PURINE DERIVATIVE; CROSS-COUPLINGS; FERROCENE-MODIFIED PURINE; FERROCENES; FLUORINATED COMPOUND; NUCLEOSIDE; PURINE DERIVATIVES; SOLID PHASE SYNTHESIS;

SCAFFOLDS;

EID: 78649939570     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527210793358240     Document Type: Article

References (127)

1. Bobek, M.; Bloch, A.; Parthasarathy, R.; Whistler, R.L. Synthesis and biological activity of 5-fluoro-4'-thiouridine and some related nucleosides. J. Med. Chem., 1975, 18, 784-787.
2. Ototani, N.; Whistler, R.L. Preparation and antitumor activity of 4'-thio analogs of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine. J. Med. Chem., 1974, 17, 535-537.
3. Bobek, M.; Whistler, R.L.; Bloch, A. Synthesis and biological activity of pyrazines and pyrazine ribonucleosides as pyrimidine analogs. J. Med. Chem., 1972, 15, 168-171.
4. Nie, A.; Wang, J.; Huang, Z. Microwave-assisted solution-phase parallel synthesis of 2,4,6-trisubstituted pyrimidines. J. Comb. Chem., 2006, 8, 646-648.
5. Fredholm, B.B.; IJzerman, A. P.; Jacobson, K.A.; Klotz, K.N. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. J. Pharmacol. Rev., 2001, 53, 527-552.
6. Bressi, J.C.; Verlinde, C.L.M.J.; Aronov, A.M.; Shaw, M.L.; Shin, S.S.; Nguyen, L.N.; Suresh, S.; Buckner, F.S.; Van Voorhis, W.C.; Kuntz, I.D.; Hol, W.G.J.; Gelb, M.H. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure- based drug design. J. Med. Chem., 2001, 44, 2080-2093.
7. Harmse, L.; Gray, N.; Schultz, P.; Leclerc, S.; Meijer, D.C.; Havli, I. Structure- activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum. Biochem. Pharmacol., 2001, 62, 341-348.
8. Meijer, L.; Raymond, E. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc. Chem. Res., 2003, 36, 417-425.
9. Bonnet, P.A.; Robins, R.K. Modulation of leukocyte genetic expression by novel purine nucleoside analogues. A new approach to antitumor and antiviral agents. J. Med. Chem., 1993, 36, 635-653.
10. Chen, X.; Kern, E.R.; Drach, J.C.; Gullen, E.; Cheng, Y.C.; Zemkicka, J. Structure-activity relationships of (S,Z)-2-aminopurine methylenecyclopropane analogues of nucleosides. Variation of purine-6 substituents and activity against herpesviruses and hepatitis B virus. J. Med. Chem., 2003, 46, 1531-1537.
11. Rosemeyer, H. The chemodiversity of purine as a constituent of natural products. Chem. Biodivers., 2004, 1, 361-401.
12. Hocek, M. Syntheses of Purines Bearing Carbon Substituents in Positions 2, 6 or 8 by Metal- or Organometal-Mediated C-C Bond-Forming Reactions. Eur. J. Org. Chem., 2003, 245-254.
13. Legraverend, M. Recent advances in the synthesis of purine derivatives and their precursors. Tetrahedron, 2008, 64, 8585-8603.
14. Gallo, M.A.; Espinosa, A.; Campos, J.M. Thermal N-9' N-7' Isomerization of (6'-Substituted)-9-(2,3-Dihydro-5H-1,4-Benzodioxepin-3-yl)-9HPurines in Solution: Mechanistic Aspects. Mini-Rev. Org. Chem., 2008, 5, 128-133.
15. Laufer, S.A.; Domeyer, D.M.; Scior, T.R.F.; Albrecht, W.; Hauser, D.R.J. Synthesis and biological testing of purine derivatives as potential ATPcompetitive kinase inhibitors. J. Med. Chem., 2005, 48, 710-722.
16. Kelley, J.L.; Sokoro, F.E. 9-(2-Fluorobenzyl)-6-(methylamino)-9H-purine hydrochloride. Synthesis and anticonvulsant activity. J. Med. Chem., 1986, 29, 1133-1134.
17. Mackenzie, G.; Wilson, H.A.; Shaw, G.; Ewing D. Purines, pyrimidines, and imidazoles. Part 64. Alkylation and acylation of some aminoimidazoles related to intermediates in purine nucleotide de novo and thiamine biosynthesis. J. Chem. Soc. Perkin Trans. 1, 1988, 9, 2541-2546.
18. Cusack, N.J.; Shaw, G.; Logemann, F.I. Purines, pyrimidines, and imidazoles. Part 54. Interconversion of some intermediates in the de novo biosynthesis of purine nucleotides. J. Chem. Soc. Perkin Trans. 1, 1980, 10, 2316-2321.
19. Thomas, H.J.; Avery, L.N.; Brockman, R.W.; Montgomery, J.A. 5-Amino-4- (diazoacetyl)-1-beta-D-ribofuranosylimidazole, a new antileukemic agent. J. Med. Chem., 1987, 30, 431-434.
20. Imai, K.; Marumoto, R.; Kobayashi, K.; Yoshioka, Y.; Toda, J. Honjo, M. Synthesis of compounds related to inosine 5'-phosphate and their flavor enhancing activity. IV. 2-Substituted inosine 5'-phosphates. Chem. Pharm. Bull., 1971, 19, 576-586.
21. Bourguignon, J.-J.; Désaubry, L.; Raboisson, P.; Wermuth, C.G.; Lugnier, C. 9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors. J. Med. Chem., 1997, 40, 1768-1770.
22. Kelley, J.L.; Linn, J.A.; Selway, J.W.T. Synthesis and structure-activity relationships of 2-substituted-6-(dimethylamino)-9-(4-methylbenzyl)-9Hpurines with antirhinovirus activity. J. Med. Chem., 1989, 30, 218-224.
23. Montgomery, J.A.; Temple, C. Synthesis of Potential Anticancer Agents. XXVI. The Alkylation of 6-Chloropurine. J. Am. Chem. Soc., 1961, 83, 630-635.
24. Pérez-Pérez, M.-J.; Rozenski, J.; Busson, R.; Herdwijn, P. Application of the Mitsunobu-Type Condensation Reaction to the Synthesis of Phosphonate Derivatives of Cyclohexenyl and Cyclohexanyl Nucleosides. J. Org. Chem., 1995, 60, 1531-1537.
25. Ciapetti, P.; Soccolini, F.; Taddei, M. Synthesis of N-Fmoc-amino acids carrying the four DNA nucleobases in the side chain. Tetrahedron, 1997, 53, 1167-1179.
26. Boon, W.R.; Jones, W.G.M.; Ramage, G.R. Pteridines I. An unambiguous synthesis of 7,8-dihydro-6-hydroxypteridines. J. Chem. Soc., 1951, 96-102.
27. Yang, J.; Dang, Q.; Liu, J.; Wei, Z.; Wu, J.; Bai, X. Preparation of a fully substituted purine library. J. Comb. Chem., 2005, 7, 474-482.
28. Gaulon, C.; Dijkstra, H., Springer, C. Synthesis, 2005, 13, 2227.;
29. Fu, H.; Lam, Y. Traceless solid-phase synthesis of N1, N7-disubstituted purines. J. Comb. Chem., 2005, 7, 734-738
30. Geen, G.; Grinter, T.; Kincey, P.; Jarvest, R. The effect of the c-6 substituent on the regioselectivity of n-alkylation of 2-aminopurines. Tetrahedron, 1990, 46, 6903-6914.
31. Liu, J.; Dang, Q.; Wei, Z.; Shi, F.; Bai, X. An efficient and regiospecific strategy to N7-substituted purines and its application to a library of trisubstituted purines. J. Comb. Chem., 2006, 8, 410-416.
32. Liu, J.; Dang, Q.; Wei, Z.; Zhang, H.; Bai, X. Parallel solution-phase synthesis of a 2,6,8,9-tetrasubstituted purine library via a sulfur intermediate. J. Comb. Chem., 2005, 7, 627-636.
33. Ding, S.; Gray, N.S.; Ding, Q.; Wu, X.; Schultz, P.G. Resin-capture and release strategy toward combinatorial libraries of 2,6,9-substituted purines. J. Comb. Chem., 2002, 4, 183-186;
34. Brun, V.; Legraverend, M.; Grierson, D.S. Cyclin-dependent kinase (CDK) inhibitors: development of a general strategy for the construction of 2,6,9-trisubstituted purine libraries. Part 1. Tetrahedron Lett., 2001, 42, 8161-8164;
35. Brun, V.; Legraverend, M.; Grierson, D.S. Cyclin-dependent kinase (CDK) inhibitors: development of a general strategy for the construction of 2,6,9-trisubstituted purine libraries. Part 2. Tetrahedron Lett., 2001, 42, 8165-8167
36. Brun, V.; Legraverend, M.; Grierson, D.S. Cyclin-dependent kinase (CDK) inhibitors: development of a general strategy for the construction of 2,6,9-trisubstituted purine libraries. Part 3. Tetrahedron Lett., 2001, 42, 8169-8171.
37. Viña, D.; Santana, L.; Uriarte, E.; Terán, C. 1,2-Disubstituted cyclohexane nucleosides: comparative study for the synthesis of cis and trans adenosine analogues. Tetrahedron, 2005, 61, 473-476.
38. Viña, D.; Santana, L.; Uriarte, E.; Quezada, E.; Valencia, L. Synthesis of 1- [2-(Hydroxymethyl)cyclohexyl]pyrimidine Analogues of Nucleosides: A Comparative Study. Synthesis, 2004, 15, 2517-2522.
39. Yahyazadeh, A.; Habibi, F. Synthesis and characterization of 9-phenyl-9Hpurin- 6-amines from 5-amino-1-phenyl-1H-imidazole-4-carbonitriles. E-J. Chem., 2007, 4, 372-375.
40. Al-Azmi, A.; Elassar, A.A.; Abdel-Zaher, A.; Booth, B.L. The chemistry of diaminomaleonitrile and its utility in heterocyclic synthesis. Tetrahedron, 2003, 59, 2749-2763.
41. Al-Azini, A.; Booth, B.L.; Carpenter, R.A.; Carvalho, A.; Marrelec, E; Pritchard, R.G.; Proença, M.F.J.R.P. Facile synthesis of 6-cyano-9- substituted-9H-purines and their ring expansion to 8-(arylamino)-4-imino-3- methylpyrimidino[5,4-d] pyrimidines. J. Chem. Soc. Perkin 1, 2001, 2532-2537.
42. Yahyazadeh, A.; Pourrostam, B.; Rabiee, M. Synthesis of 9-benzyl-6- aminopurines from 5-amino-1-benzyl-4-cyanoimidazoles. Bull. Korean Chem. Soc., 2003, 24, 1723-1724.
43. Correia, C.; Carvalho, M.A.; Proença, M.F. Synthesis and in vitro activity of 6-amino-2,9-diarylpurines for Mycobacterium tuberculosis. Tetrahedron, 2009, 65, 6903-6911.
44. Alves, M.J.; Carvalho, M.A.; Carvalho, S.; Dias, A.M.; Fernandes, F.H.; Proença, M.F. A New Approach to the Synthesis of N, N-Dialkyladenine Derivatives. Eur. J. Org. Chem., 2007, 4881-4887.
45. Dias, A.M.; Vila-Chã, S.; Cabral, I.; Proença, M.F. A versatile synthetic approach for isoguanine derivatives. Synlett, 2007, 8, 1231-1233.
46. Dias, A.M.; Cabral, I.; Vila-Chã, A.S.; Costa, D.S.; Proença, M.F. The Synthesis of 6-Amidino-2-oxopurine Revisited: New Evidence for the Reaction Mechanism. Eur. J. Org. Chem., 2007, 1925-1934.
47. Carvalho, M.A.; Zaki, M.E.A.; Álvares, Y.; Proença, M.F.; Booth, B.L. Synthesis of novel 6-enaminopurines. Org. Biomol. Chem., 2004, 2, 2340-345.
48. Booth, B.L.; Dias, A.M.; Proença, M.F.; Zaki, M.E.A. The Reactions of aminomaleonitrile with Isocyanates and Either Aldehydes or Ketones Revisited. J. Org. Chem., 2001, 66, 8436-8441.
49. Booth, B.L.; Cabral, I.M.; Dias, A.M.; Freitas, A.P.; Matos Beja, A.M.; roença, M.F.; Ramos Silva, M. A new and efficient approach to the synthesis f 6-amidino-2-oxopurines. J. Chem. Soc., Perkin Trans 1, 2001, 1241-251.
50. Matsuda, A.; Shinozaki, M.; Yamaguchi, T.; Homma, H.; Nomoto, R.; iyasaka, T., Watanabe, Y.; Abiru, T. Nucleosides and nucleotides. 103. 2- lkynyladenosines: a novel class of selective adenosine A2 receptor agonists ith potent antihypertensive effects. J. Med. Chem., 1992, 35, 241-252.
51. Volpini, R.; Costanzi, S.; Lambertucci, C.; Taffi, S.; Vittori, S.; Klotz, K.-N.; ristalli, G. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective gonists at the human adenosine A(3) receptor and a starting point for earching A(2B) ligands. J. Med. Chem., 2002, 45, 3271-3279.
52. Hocek, M.; Holy, A.; Votruba, I.; Dvoráková, H. Synthesis and cytostatic ctivity of substituted 6-phenylpurine bases and nucleosides: application of he Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids. J. Med. Chem., 2000, 43, 1817-1825.
53. Lakshman, M.K.; Hilmer, J.H.; Martin, J.Q.; Keeler, J.C.; Dinh, Y.Q.V.; gassa, F.N.; Russon, L.M. Palladium Catalysis for the Synthesis of Hydrophobic -6 and C-2 Aryl 2'-Deoxynucleosides. Comparison of C-C versus C-N Bond Formation as well as C-6 versus C-2 Reactivity. J. Am. Chem. Soc., 2001, 123, 7779-7787.
54. Vélez, E.A.; Beal, P.A. 6-Bromopurine Nucleosides as Reagents for Nucleoside nalogue Synthesis. J. Org. Chem., 2001, 66, 8592-8598.
55. Liu, J.; Janeba, Z.; Robins, M.J. SNAr Iodination of 6-Chloropurine Nucleosides: romatic Finkelstein Reactions at Temperatures Below 40 °C. Org. Lett., 2004, 6, 2917-2919.
56. Resnati, G. Synthesis of chiral and bioactive fluoroorganic compounds Tetrahedron, 1993, 49, 9385-9445
57. Hocek, M.; Holy A. Perfluoroalkylation of 6-iodopurines by trimethyfluoroalkyl)silanes. Synthesis of 6-(perfluoroalkyl)purine bases, ucleosides and acyclic nucleotide analogs. Collect. Czech. Chem. Commun., 1999, 64, 229-241.
58. Gurvich, V.; Kim, H.-Y.; Hodge, R.P.; Harris, C.M.; Harris, Th.M. Utilization of Tetrabutylammonium Triphenyldifluorosilicate (TBAT) In The Synthesis f 6-Fluoropurine Nucleosides. Nucleosides & Nucleotides, 1999, 18, 327-2333.
59. Pilcher, A.S.; DeShong, P. Utilization of Tetrabutylammonium Triphenyldifluorosilicate s a Fluoride Source for Silico-Carbon Bond Cleavage. J. rg. Chem., 1996, 61, 6901-6905.
60. Liu, J.; Robins, M.J. Fluoro, Alkylsulfanyl, and Alkylsulfonyl Leaving roups in Suzuki Cross-Coupling Reactions of Purine 2'-Deoxynucleosides nd Nucleosides. Org. Lett., 2005, 7, 1149-1151.
61. Liu, J.; Robins, M.J. SNAr Displacements with 6-(Fluoro, Chloro, Bromo, odo, and Alkylsulfonyl)purine Nucleosides: Synthesis, Kinetics, and echanism. J. Am. Chem. Soc., 2007, 129, 5962-5968.
62. Kuchar, M.; Radek, P.; Votruba, I.; Hocek, M. Synthesis of Purines Bearing unctionalized C-Substituents by the Conjugate Addition of Nucleophiles to -Vinylpurines and 6-Ethynylpurines. Eur. J. Org. Chem., 2006, 5083-5098.
63. Øveras A.T.; Bakkestuen, A.K.; Gundersen, L.-L.; Rise, F. Addition of ucleophiles to 6-vinylpurines. Acta Chem. Scand., 1997, 51, 1116-1124.
64. Hocek, M., Star I.; Stará, I.G.; Dvoráková, H. Covalent analogues of DNA ase-pairs and triplets IV+. Synthesis of trisubstituted benzenes bearing urine and/or pyrimidine rings by cyclotrimerization of 6-ethynylpurines nd/or 5-ethynyl-1,3-dimethyluracil. Collect. Czech. Chem. Commun., 2002, 7, 1223-1235.
65. Moonen, K.; Laureyn, I.; Stevens, C.V. Synthetic Methods for Azaheterocyclic hosphonates and Their Biological Activity. Chem. Rev., 2004, 104, 177-6216.
66. Muruganantham, R.; Mobin, S.M.; Namboothiri, I.N.N. Org. Lett., 2007, 1125.;
67. Alen, J.; Dobrzanska, L.; De Borggraeve, W.M.; Compernolle, F. Synthesis of 2(1H)-Pyrazinone Phosphonates via an Arbuzov-type Reaction. Org. Chem., 2007, 72, 1055-1057;
68. Al Quntar, A.A.A.; Srivastava, K.; Srebnik, M.; Melman, A.; Ta-Shma, R.; Shurki, A. Formation of Diethyl -Amino-1-cyclopentenylphosphonates: A Simple Synthesis with a Unique Mechanism. J. Org. Chem., 2007, 72, 4932-4935;
69. Moriguchi, T.; Yanagi, T.; unimori, M.; Wada, T.; Sekine, M. Synthesis and Properties of minoacylamido-AMP: Chemical Optimization for the Construction of an -Acyl Phosphoramidate Linkage. J. Org. Chem., 2000, 65, 8229-8238.
70. Qu, G.-R.; Xia, R.; Yang, X.-N.; Li, J.-G.; Wang, D.-Ch.; Guo, H.-M. Synthesis f Novel C6-Phosphonated Purine Nucleosides under Microwave Irradiation y SNA Arbuzov Reaction. J. Org. Chem., 2008, 73, 2416-2419.
71. Alarcón, K.; Martelli, A.; Demeunynck, M.; Lhomme, J. 2-Amino-6-(1,2,4- riazol-4-yl)-purine: A useful intermediate in the synthesis of 9-alkylguanines. Tetrahedron Lett., 2000, 41, 7211-7215.
72. Bakkestuen, A.K.; Gundersen, L.-L. Regioselective N-9 arylation of purines mploying arylboronic acids in the presence of Cu(II). Tetrahedron Lett., 2003, 44, 3359-3362.
73. Zhong, M.; Nowak, I.; Cannon, J.F.; Robins, M.J. Structure and Synthesis of -(Substituted-imidazol-1-yl)purines: Versatile Substrates for Regiospecific lkylation and Glycosylation at N9. J. Org. Chem., 2006, 71, 4216-4221.
74. Kralj, M.; Koji-Prodi, B.; Bani, Z.; Grdia, M.; Vela, V.; Synthesis, structural characterization and cytotoxic effect of 6- mino-6-deoxy- -ascorbic acid derivatives. Eur. J. Med. Chem., 1996, 31, 3-35.
75. De lerq, E.D.; Mintas, M. Novel pyrimidine and purine derivatives of Lascorbic cid: synthesis and biological evaluation. J. Med. Chem., 1999, 42, 673-2678.
76. Dallaker, F.; Sanders, J. L-Ascorbic acid derivatives, 1. Preparation and roperties of O2,O3-ethanediyl- and O2,O3-dibenzyl-L-ascorbic acids. Hemiker-Zeitung, 1985, 109, 197-202.
77. Dallaker, F.; Sanders, J. Derivatives of L-ascorbic acid. 2. Preparation of eoxy-L-ascorbic acid. Chemiker-Zeitung, 1985, 109, 277-280.
78. Ogilvie, K.K.; Proba, Z.A. Synthesis of Purine and Pyrimidine rihydroxyacyclonucleosides. Ucleosides Nucleotides, 1984, 3, 537-547.
79. Deghati, P.Y.F.; Wanner, M.J.; Koomen, G.-J. Regioselective nitration of urine nucleosides: synthesis of 2-nitroadenosine and 2-nitroinosine. Tetrahedron Lett., 2000, 41, 1291-1295.
80. Koch, M.; Den Hartog, J.A.J.; Koomen, G.-J.; Wanner, M.J.; Feenstra, R.W. O Patent 2006027365 A1 20060316, 2006; Chem. Abstr., 2006, 144, 92979.
81. Imbach, P.; Capraro, H.G.; Furet, P.; Mett, H.; Meyer, T.; Zimmermann, J.,6,9-trisubstituted purines: optimization towards highly potent and selective DK1 inhibitors. Bioorg. Med. Chem. Lett., 1999, 9, 91-96.
82. Nair, V.; Sallis, T.B. Copper mediated reactions in nucleoside synthesis. Tetrahedron Lett., 1990, 31, 807-811.
83. Taddei, D.; Kilian, P.; Slawin, A.M.Z.; Woollins, J.D. Synthesis and full haracterisation of 6-chloro-2-iodopurine, a template for the functionalisation of purines. Org. Biomol. Chem., 2004, 2, 665-670.
84. Kato, K.; Hayakawa, H.; Tanaka, H.; Kumamoto, H.; Shindo, S.; Shuto, S.; Miyasaka, T. A New Entry to 2-Substituted Purine Nucleosides Based on Lithiation-Mediated Stannyl Transfer of 6-Chloropurine Nucleosides. J. Org. hem., 1997, 62, 6833-6841.
85. Brun, V.; Legraverend, M.; Grierson, D.S. Traceless solid-phase synthesis of 2,6,9-trisubstituted purines from resin bound 6-thiopurines. Tetrahedron, 2002, 58, 7911-7923.
86. Kim, H.O.; Schinazi, R.F.; Shanmuganathan, K.; Jeong, L.S.; Beach, J.W.; Nampalli, S.; Cannon, D.L.; Chu, C.K. L-beta-(2S,4S)- and L-alpha-(2S,4R)- dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis nd structure-activity relationships. J. Med. Chem., 1993, 36, 519-528.
87. Fiorini, M.T.; Abell, C. Solution-phase synthesis of 2,6,9-trisubstituted purines. Tetrahedron Lett., 1998, 39, 1827-1830.
88. Din, S.; Gray, N.S.; Wu, X.; Ding, Q.; Schultz, P.G. A Combinatorial Scaffold approach toward Kinase-Directed Heterocycle Libraries. J. Am. Chem. oc., 2002, 124, 1594-1596.
89. Austin, R.E.; Okonya, J.F.; Bond, D.R.S.; Al-Obeidi, F. Microwave-assisted solid-phase synthesis (MASS) of 2,6,9-trisubstituted purines. Tetrahedron Lett., 2002, 43, 6169-6171.
90. Conejo-García, A.; Núñez, M.C.; Marchal, J.A.; Rodríguez-Serrano, F.; Aránega, A.; Gallo, M.A.; Espinosa, A.; Campos, J.M. Regioespecific Microwave- ssisted Synthesis and Cytotoxic Activity against Human Breast ancer Cells of (RS)-6-Substituted-7- or 9-(2,3-Dihydro-5H-1,4- enzodioxepin-3-yl)-7H- or -9H-Purines. Eur. J. Med. Chem., 2008, 43, 1742-1748.
91. Vorbrüggen, B.; Bennua, B. Nucleoside syntheses. XXV. A new simplified nucleoside synthesis. Chem. Ber., 1981, 114, 1279-1286.
92. Saniger, E.; Campos, J.M.; Entrena, A.; Marchal, J.A.; Suárez, I.; Aránega, A.; Choquesillo.; Niclós, J.; Gallo, M.A.; Espinosa, A. Medium Benzenefused xacycles with the 5-Fluorouracil Moiety: Synthesis, Antiproliferative ctivities and Apoptosis Induction in Breast Cancer Cells. Tetrahedron, 2003, 59, 5457-5467.
93. Griffin, R.J.; Calvert, A.H.; Curtin, N.J.; Newell, D.R.; Golding, B.T.; Endicott, A.; Noble, M.E.; Boyle, F.T.; Jewsbury, P.J. G.B. Patent 9,902,162, 998; Chem. Abstr., 1999, 130, 139576.
94. Saunders, D.E.; Lawrence, W.D.; Christensen, C.; Wappler, N.L.; Ruan, H.; eppe, G. Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int. J. cancer, 1997, 70, 214-220.
95. Yosief, T.; Rudi, A.; Stein, Z.; Golberg, I.; Gravalos, G.M.D.; Schleyer, M.; Kashman, Y. Asmarines A-C.; Three novel cytotoxic metabolites from he marine sponge Raspailia sp. Tetrahedron Lett., 1998, 39, 3323-3326;
96. Osief, T.; Rudi, A.; Kashman, Y. Asmarines A-F, Novel Cytotoxic Compounds rom the Marine Sponge Raspailia Species. J. Nat. Prod., 2000, 63, 99-304;
97. Rudi, A.; Shalom, H.; Schleyer, M.; Banayahu, Y.; Kashman, Y. Asmarines G and H and Barekol, Three New Compounds from the Marine ponge Raspailia sp. J. Nat. Prod., 2004, 67, 106-109
98. Rudi, A.; Aknin, M.; Gaydoy, E.; Kashman, Y. Asmarines I, J, and K and Nosyberkol: Four New Compounds from the Marine Sponge Raspailia sp. J. Nat. Prod., 2004, 7, 1932-1935.
99. Vik, A.; Gundersen, L.-L. Synthetic studies directed towards asmarines; onstruction of the tetrahydrodiazepinopurine moiety by ring closing metathesis. Etrahedron Lett., 2007, 48, 1931-1934.
100. Dalby, C.; Bleasdale, C.; Clegg, W.; Elsegood, M.R.J.; Golding, B.T.; Griffin, J. Regiospecific Alkylation of 6-Chloropurine and 2,6-Dichloropurine t N7 by Transient Protection of N3/N9 by Methylcobaloxime. Angew. hem. Int. Ed. Engl., 1993, 32, 1696-1697.
101. Phillips, A.J.; Abell, A.D. Ring-Closing Metathesis of Nitrogen-Containing ompounds: Applications to Heterocycles, Alkaloids, and Peptidomimetics Aldrichim. Acta, 1999, 32, 75-89.
102. Miller, S.J.; Kim, S.-H.; Chen, Z.-R.; Grubbs, R.H. Catalytic Ring-Closing etathesis of Dienes: Application to the Synthesis of Eight-Membered ings. J. Am. Chem. Soc., 1995, 117, 2108-2109;
103. Kirkland, T.A.; Grubbs, H. Effects of Olefin Substitution on the Ring-Closing Metathesis of Dienes. J. Org. Chem., 1997, 62, 7310-7318;
104. Martin, S.F.; Humphrey, J.M.; li, A.; Hillier, M. Enantioselective Total Syntheses of Ircinal A and Related Manzamine Alkaloids. J. Am. Chem. Soc., 1999, 121, 866-867
105. Rodríguez, R.; Castedo, L.; Mascareñas, J.L. An Expeditious Route to Eight- and Nine- embered Carbocycles Based on a RCM-Ring Fragmentation Strategy. Org. ett., 2000, 2, 3209-3212.
106. White, J.D.; Hrnciar, P.; Yokochi, A.F.T. Tandem Ring-Closing Metathesis ransannular Cyclization as a Route to Hydroxylated Pyrrolizidines. Asymmetric ynthesis of (+)-Australine. J. Am. Chem. Soc., 1998, 120, 7359-7360.
107. Rutjes, F.P.J.T.; Schoemaker, H.E. Ruthenium-catalyzed ring closing olefin etathesis of non-natural -amino acids. Ruthenium-catalyzed ring closing lefin metathesis of non-natural -amino acids. Tetrahedron Lett., 1997, 38, 677-680.
108. Tunçbilek, M.; Ates-Algöz, Z.; Atlantar, N.; Karayel, A.; Özbey, S. Synthesis nd antimicrobial evaluation of some new substituted purine derivatives. Bioorg. Med. Chem., 2009, 17, 1693-1700.
109. Jacobson, K.A.; Daly, J.W.; Manganiello, V. Purines in cellular signaling: argets for new drugs; Springer: New York, 1990.
110. Norbory, C.; Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 1992, 61, 441-470;
111. Morgan, D. Cyclin-dependent kinases: engines, locks, and microprocessors. Annu. Rev. Cell Dev. Biol., 1997, 13, 61-291
112. Hengst, L.; Reed, S.I. Inhibitors of the Cip/Kip family. Curr. opics Microb. Immunol., 1998, 227, 25-41.
113. Bakkestuen, A.K.; Gundersen, L.-L.; Langli, G.; Liu, F.; Nolsoe, J.M. 9- enzylpurines with inhibitory activity against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett., 2000, 10, 1207-1210;
114. Scozzafava, A.; Mastrolorenzo, A.; Supuran, C.T. Antimycobacterial activity of 9- ulfonylated/sulfenylated-6-mercaptopurine derivatives. Bioorg. Med. Chem. Lett., 2001, 11, 1675-1678;
115. Gundersen, L.-L.; Nissen-Meyer, J.N.; Spilsberg, B. Synthesis and antimycobacterial activity of 6-arylpurines: the requirements or the N-9 substituent in ctive antimycobacterial purines. J. Med. Chem., 2002, 45, 1383-1386.
116. Pathak, A.K.; Pathak, V.; Seitz, L.E.; Suling, W.J.; Reynolds, R.C. Antimycobacterial gents. 1. Thio analogues of purine. J. Med. Chem., 2004, 47, 73-276.
117. Wang, J.-L.; Xu, J.-M.; Lv, D.-S.; Lin, X.-F. Promiscuous enzyme-catalyzed regioselective Michael addition of purine derivatives to α,β-unsaturated carbonyl ompounds in organic solvent. Tetrahedron, 2009, 65, 2531-2536.
118. Takvorian, A.G.; Combs, A.P. Microwave-assisted organic synthesis using inivials to optimize and expedite the synthesis of diverse purine libraries. J. Comb. Chem., 2004, 6, 171-174.
119. van Staveren, D.; Metzler-Nolte, N. Bioorganometallic Chemistry of Ferrocene. Hem. Rev., 2004, 104, 5931-5986.
120. Meunier, P.; Quattara, L.; Gautheron, B.; Tirouflet, J.; Camboli, D.; Besançon, J.; Boulay, F. Synthèse, caractérisation et propriétés cytotoxiques des remiers 'métallocénonucléosides'. Eur J. Med. Chem., 1991, 26, 351-362.
121. Hocek, M.; Ferrocene-Modified Purines as Potential Electrochemical Markers ynthesis, Crystal Structures, Electrochemistry and Cytostatic Activity of Ferrocenylethynyl)- and Ferrocenylethyl)purines. Chem. Eur. J., 2004, 10, 2058-2066.
122. Rosenblum, M.; Brawn, N.; Papenmeier, J.; Applebaum, M. Synthesis of errocenylacetylenes. J. Organomet. Chem., 1996, 6, 173-180.
123. Gundersen, L.-L.; Bakkestuen, A.K.; Aasen, A.J.; Øveras, H.; Rise, F. 6- alopurines in palladium-catalyzed coupling with organotin and organozinc eagents. Tetrahedron, 1994, 50, 9743-9756.
124. Huang, H.; Liu, H.; Chen, K.; Jiang, H. Microwave-assisted rapid synthesis f 2,6,9-substituted purines. J. Comb. Chem., 2007, 9, 197-199.
125. Qu, G.-R.; Mao, Z.-J.; Niu, H.; Wang, D.-Ch.; Xia, Ch.; Guo, H.-M. Straightforward and Hghly Efficient Catalyst-Free One-Step Synthesis of 2- Purin-6-yl)acetoacetic Acid Ethyl Esters, (Purin-6-yl)acetates, and - ethylpurines through SNAr-Based Reactions of 6-Halopurines with Ethyl cetoacetate. Org. Lett., 2009, 11, 1745-1748.
126. Hammarstrom, L.G.J.; Smith, D.B.; Talamas, F.X.; Labadie, S.S.; Krauss, E. Utility of 4,6-dichloro-2-(methylthio)-5-nitropyrimidine. An efficient olid-phase synthesis of olomoucine. Tetrahedron Lett., 2002, 43, 8071-8073
127. Hammarstrom, L.G.J.; Meyer, M.E.; Smith, D.B.; Talamas, F.X. Utility of 4,6-dichloro-2-(methylthio)-5-nitropyrimidine. Part 2: Solution hase synthesis of tetrasubstituted purines. Tetrahedron Lett., 2003, 44, 361-8363.